Back to Ovarian Cancer
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT05629858

NCT05629858
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

  • You have been diagnosed with Polycystic Ovary Syndrome (PCOS) based on having at least two of these three features: signs of high male hormones (such as excess hair, acne, or oily skin) or high hormone levels on a blood test; ovaries that look polycystic on an ultrasound; or irregular periods (cycles longer than 35 days or fewer than 7 periods per year).
  • Your Body Mass Index (BMI) is between 25 and 50 (a measure of weight relative to height — confirm with trial site if unsure of your BMI).
  • You are between 18 and 45 years old.

Who may not be able to join:

  • You have not had a period for more than 2 years (meaning you have gone through menopause).
  • You have been diagnosed with type 1 or type 2 diabetes.
  • You have previously been diagnosed with a depressive mood disorder by a doctor or psychologist.
  • You have a history of an eating disorder, such as anorexia, bulimia, or binge eating disorder.
  • Your weight has not been stable for at least 3 months before the study starts.
  • You are currently taking certain medications, such as the contraceptive pill, weight loss drugs, insulin-sensitising medications, hormone-blocking drugs, anti-seizure drugs, or antipsychotic medications (within 2 months of starting the study).
  • You are already following a time-restricted eating (TRE) plan, which involves limiting the hours of the day during which you eat (confirm with trial site).
  • You are a competitive athlete or do more than 1 hour of intense exercise on more than 5 days per week.
  • You have smoked within the last 3 months before starting the study.
  • You do not have a Wi-Fi connection at home, as video calls are required.
  • You are pregnant or are trying to become pregnant.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
University of Illinois at Chicago
Registry
clinicaltrials_gov
Start date
15 January 2023
Est. completion
15 December 2024

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in percent body weight

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov